UBS Group
AIH

UBS Group’s Aesthetic Medical International Holdings AIH Stock Holding History

UBS Group’s Portfolio AIH Stock Details AIH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-70
Closed -$45 – 10222
2023
Q3 		$45 Buy
+70
New +$60 ﹤0.01% 9026
2023
Q2 		– Sell
-33
Closed -$41 – 9981
2023
Q1 		$41 Sell
33
-3,739
-99% -$5.31K ﹤0.01% 9360
2022
Q4 		$4.87K Buy
3,772
+272
+8% +$383 ﹤0.01% 9264
2022
Q3 		$6K Sell
3,500
-2,530
-42% -$5.21K ﹤0.01% 9102
2022
Q2 		$13K Buy
6,030
+1,251
+26% +$2.12K ﹤0.01% 7572
2022
Q1 		$8K Buy
4,779
+3,790
+383% +$10.7K ﹤0.01% 8726
2021
Q4 		$3K Buy
+989
New +$3.56K ﹤0.01% 9715
2021
Q2 		– Sell
-4,090
Closed -$30K – 9961
2021
Q1 		$30K Buy
4,090
+2,120
+108% +$13.7K ﹤0.01% 7022
2020
Q4 		$10K Sell
1,970
-1,482
-43% -$7.87K ﹤0.01% 7511
2020
Q3 		$15K Sell
3,452
-8,525
-71% -$40.6K ﹤0.01% 6544
2020
Q2 		$74K Buy
11,977
+9,768
+442% +$77K ﹤0.01% 5547
2020
Q1 		$20K Sell
2,209
-2,861
-56% -$22.9K ﹤0.01% 6506
2019
Q4 		$33K Buy
+5,070
New +$36.7K ﹤0.01% 6592

Other funds holding AIH

ITVII
IDG Technology Venture Investment IV Hong Kong $58.3M AUM 89.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

UBS Group's AIH Position: Q4 2023 in Review

UBS Group sold out of Aesthetic Medical International Holdings (AIH) in Q4 2023, closing a stake of 70 shares — an estimated $45 sold.

UBS Group first reported a position in AIH in Q4 2019 and held it in 13 quarters. The position peaked at $74K in Q2 2020. 6 funds tracked by Wall St. Rank hold AIH as of Q4 2023.

  • UBS Group reported no remaining Aesthetic Medical International Holdings position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 70 Aesthetic Medical International Holdings shares in Q4 2023, an estimated $45.
  • UBS Group first reported a position in Aesthetic Medical International Holdings in Q4 2019 and held it in 13 quarters.
  • UBS Group's Aesthetic Medical International Holdings position peaked at $74K in Q2 2020.
  • 6 funds tracked by Wall St. Rank held Aesthetic Medical International Holdings as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.